Please provide your email address to receive an email when new articles are posted on . PARIS — With 20 years experience implanting phakic IOLs in Europe, phakic IOLs have "a long history of ...

May 13, 2010 — Phakic intraocular lenses (IOLs) may be safer than excimer laser surgical correction for moderate to high myopia and appear to be preferred by patients, according to a new study ...

For extremely nearsighted patients who are seeking independence from glasses and contact lenses, implantation of a phakic IOL can be a reasonable choice. In the U.S., we have access to two different ...

May 3, 2012 (Chicago, Illinois) — Four- and 5-year data from second-eye implantation of the AcrySof Cachet phakic lens reveal stable and predictable refractive outcomes with excellent visual acuity.

To compare 3-year results of PRK–MMC and phakic intraocular lens (PIOL) implantation in patients with >8.0 diopters (D) of myopia. This study was conducted as a non-randomized clinical trial on 23 ...

There’s nothing I love to write about more than people sticking things in my eye. Although I can just barely read their website through the tears, Verisyse new Phakic Intraocular Lens (IOL) appears to ...

CHICAGO -- Posterior chamber phakic intraocular lens (IOL) implantation safely and predictably improves visual acuity over 5 years in patients with high myopia or high myopic astigmatism who are not ...

Eyebright Medical Technology (Beijing) Co. Ltd. is expanding its position in China’s phakic intraocular lens (IOL) market, gaining the National Medical Products Administration (NMPA) approval of its ...

CHICAGO - Oct. 17, 2016 - People who are unsuitable for LASIK because of moderate or extreme nearsightedness or severe astigmatism may benefit from a surgical procedure using intraocular lenses.

Eyebright Medical Technology (Beijing) Co. Ltd. is expanding its position in China’s phakic intraocular lens (IOL) market, gaining the National Medical Products Administration (NMPA) approval of its ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on ...